C

ChoA Pharmaceutical Co Ltd
KOSDAQ:034940

Watchlist Manager
ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
Watchlist
Price: 930 KRW -1.38%
Market Cap: ₩28.8B

Net Margin

-12.7%
Current
Declining
by 1.5%
vs 3-y average of -11.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-12.7%
=
Net Income
₩-7.7B
/
Revenue
₩60.5B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-12.7%
=
Net Income
₩-7.7B
/
Revenue
₩60.5B

Peer Comparison

Country Company Market Cap Net
Margin
KR
ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
28.8B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Lower than 81% of companies in Korea
Percentile
19th
Based on 2 632 companies
19th percentile
-12.7%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

ChoA Pharmaceutical Co Ltd
Glance View

Market Cap
28.8B KRW
Industry
Pharmaceuticals

ChoA Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicine and health supplement food. The company is headquartered in Seoul, Seoul. The Company’s products are mainly for treatment of indigestion, gastric ulcer, duodenal ulcer, gastritis, gastric hyperacidity, intestinal disorder, constipation, diarrhea, stomachache, calcium deficiency, fatigue, iron deficiency anemia, neurasthenia, hypertension, hyperlipidemia, circulatory disorder, medicine poisoning, hepatic disease, allergic rhinitis, cough, cold, rheumatoid arthritis and others. The company also provides nutrition products, health drinks, mixed drinks, beverages for children, cosmetics and others.

Intrinsic Value
1 596.93 KRW
Undervaluation 42%
Intrinsic Value
Price
C
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-12.7%
=
Net Income
₩-7.7B
/
Revenue
₩60.5B
What is ChoA Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for ChoA Pharmaceutical Co Ltd is -12.7%, which is below its 3-year median of -11.2%.

How has Net Margin changed over time?

Over the last 3 years, ChoA Pharmaceutical Co Ltd’s Net Margin has decreased from -8.1% to -12.7%. During this period, it reached a low of -21.3% on Sep 30, 2024 and a high of 2.9% on Jun 30, 2023.

Back to Top